For Immediate Release Contact email@example.com
April 1, 2009
TUSTIN, California — April 1, 2009 — Improving the ability to provide top-tier patient service during interventional procedures, Toshiba America Medical Systems, Inc. has introduced Next Generation Advanced Image Processing (AIP) available on its Infinix™-i X-ray product line. Next Generation AIP was tested and evaluated by Dr. Vinit Lal, interventional cardiologist, HeartPlace, who noted the upgraded processor has increased accuracy and improved workflow and helped ensure excellent patient care.
“As the first in the country to work hands-on with Next Generation AIP, I have been extremely impressed with the images produced,” said Dr. Lal. “This upgraded processor is increasing workflow, patient throughput and cath lab utilization, all while providing a safer exam for the patient, which is exactly what is needed in today’s healthcare environment.”
Released in late 2008, Toshiba’s AIP feature improves patient care by increasing the quality, sharpness, and image contrast during interventional procedures. Additionally, this proprietary technology has virtually eliminated image lag, benefiting clinicians while guiding and deploying devices during fluoroscopy. Next Generation AIP further increases image clarity during interventional procedures using AIP, creating a safer, more time-efficient exam for the patient by reducing the possibility of having to re-image the patient if the image is not clear.
The benefits are particularly valuable for interventional procedures, such as stent visualization. Traditionally, images acquired during these procedures can be difficult to interpret, causing physicians like Dr. Lal to take more time to scan the patient again. Accurately visualizing coronary arteries immediately during procedures, such as stent insertion, is of upmost importance according to Dr. Lal. “If we are unable to get a clear image of the artery in need of a stent, it can prolong the procedure and possibly create complications for the patient. This new processor helps eliminate this risk by providing clearer images.”
“When we introduced Next Generation AIP, we knew it would have an immediate impact on patient care in facilities across the country,” said Robert Micer, director, X-ray Vascular Business Unit, Toshiba. “This new processor further delivers Toshiba’s dedication to improving patient care, particularly for interventional procedures.”
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 198,000 employees worldwide and annual sales of $77 billion. For more information, visit www.medical.toshiba.com.